A research team led by Professor Yong Taik Lim at the SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan ...
T-cell redirecting platforms function by enabling antigen-specific recognition or by colocalizing effector T cells with tumor ...
A new data cut of a trial pitting ivonescimab, a bispecific antibody, against Merck’s Keytruda showed the new drug helped people live longer.
Molecules called reactive oxygen species, which include so-called "free radicals," have long been viewed as damaging ...
The researchers also found that the effect could be reversed.
The data, which come from a subgroup in an earlier trial that Truist Securities called “the most relevant” to Revolution ...
“We needed some wins, and we are finally seeing some wins in small cell lung cancer with survival benefits like we have not ...
A review by University of Manchester scientists says sophisticated lab-grown tumors could help fast-track the search for new ...
A new biomaterial developed by researchers from The University of Western Australia is providing fresh insights into the way ...
Researchers have found a way to supercharge natural killer cells, powerful immune cells that can attack cancer, so they can ...
New research reveals a promising new target for treating cancer by harnessing a type of molecule previously thought to do ...
Basal cell carcinoma (BCC), also called basal cell skin cancer or basal cell cancer, is the most common type of skin cancer.